NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Subjects Analgesics, Opioid -- therapeutic use ✖Remove constraint Subjects: Analgesics, Opioid -- therapeutic use Subjects Opioid-Related Disorders -- epidemiology ✖Remove constraint Subjects: Opioid-Related Disorders -- epidemiology Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

1. Opioid use in Medicare Part D remains concerning

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opioid-Related Disorders -- epidemiology
Prescription Drug Misuse
Analgesics, Opioid -- economics
Fentanyl -- adverse effects
Prescription Drug Diversion
Humans
United States
United States. Department of Health and Human Services.

2. Opioids in Ohio Medicaid: review of extreme use and prescribing

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2018
Subject(s):
Analgesics, Opioid -- therapeutic use
Inappropriate Prescribing
Medicaid
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- prevention & control
Prescription Drug Misuse
Analgesics, Opioid -- administration & dosage
Humans
Ohio
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

3. Abuse-deterrent formulations of opioids: effectiveness and value : final evidence report

Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 8, 2017
Subject(s):
Abuse-Deterrent Formulations -- economics
Abuse-Deterrent Formulations -- statistics & numerical data
Analgesics, Opioid -- economics
Analgesics, Opioid -- therapeutic use
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- prevention & control
Prescription Drug Diversion -- statistics & numerical data
Comparative Effectiveness Research
Cost-Benefit Analysis
Delayed-Action Preparations -- economics
Delayed-Action Preparations -- therapeutic use
Drug Compounding -- economics
Drug Overdose -- mortality
Insurance Coverage -- economics
Insurance, Pharmaceutical Services -- economics
Opioid-Related Disorders -- epidemiology
Humans
United States

4. Primary care: on the front lines of the opioid epidemic

Author(s):
Bachhuber, Marcus A., author
Weiner, Janet, author
Mitchell, Julia, author
Samet, Jeffrey, author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, August 2016
Subject(s):
Opioid-Related Disorders -- diagnosis
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- epidemiology
Primary Health Care
Analgesics, Opioid -- therapeutic use
Buprenorphine -- therapeutic use
Chronic Disease
Comorbidity
Continuity of Patient Care
Delivery of Health Care, Integrated
HIV Infections -- prevention & control
HIV Infections -- transmission
Naloxone -- therapeutic use
Needle-Exchange Programs
Patient Care Management
Patient Care Team
Physician's Role
Prescription Drug Misuse
Humans
United States

5. Stem the tide: addressing the opioid epidemic

Publication:
Chicago, IL : American Hospital Association, [2017]
Subject(s):
Analgesics, Opioid -- therapeutic use
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- prevention & control
Opioid-Related Disorders -- therapy
Pain Management -- methods
Inappropriate Prescribing -- prevention & control
Opioid-Related Disorders -- economics
Pain -- drug therapy
Patient Education as Topic
Patient Transfer
Practice Patterns, Physicians'
Humans
United States

6. Concerns about opioid use in Medicare Part D in the Appalachian region

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, April 2019
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opioid-Related Disorders -- epidemiology
Drug Utilization -- statistics & numerical data
Inappropriate Prescribing -- statistics & numerical data
Prescription Drug Diversion -- statistics & numerical data
Prescription Drug Monitoring Programs
Humans
Appalachian Region
United States